Primary Effusion Lymphoma: Is Dose-Adjusted-EPOCH Worthwhile Therapy?

Primary effusion lymphoma (PEL) is a rare condition, which accounts for approximately 4% of all human immunodeficiency virus (HIV)-associated non-Hodgkin lymphomas. PEL has a predilection for body cavities and occurs in the pleural space, pericardium, and peritoneum. Without treatment, the median su...

Descripción completa

Detalles Bibliográficos
Autores principales: Jessamy, Kegan, Ojevwe, Fidelis O., Doobay, Ravi, Naous, Rana, Yu, John, Lemke, Sheila M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943741/
https://www.ncbi.nlm.nih.gov/pubmed/27462227
http://dx.doi.org/10.1159/000446315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943741/
https://www.ncbi.nlm.nih.gov/pubmed/27462227
http://dx.doi.org/10.1159/000446315

Ejemplares similares